Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
One or more suppliers on this contract have also made political donations. See supplier details below.
Project Title: NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024<br/> <br/>Offer reference number: CM/PHR/22/5678<br/> <br/>CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B. Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.<br/><br/>CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.<br/><br/>CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A. Period of framework: 1 March 2024 to 31 August 2026 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months<br/><br/>CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B). Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Abbvie Ltd | 08004972 | ~£138,947,000 estimated from lot values | 1 lot CM/PHR/22/5678/03 | LOBBYIST Policy Connect Limited (15 quarters) WA Communications Ltd (3 quarters) Portland PR Limited (3 quarters) Incisive Health Ltd (1 quarter) Political Lobbying & Media Relations Limited (1 quarter) |
| Accord-UK Ltd | 00079585 | ~£1,455,652,000 estimated from lot values | 3 lots CM/PHR/22/5678/02 · CM/PHR/22/5678/03 · CM/PHR/22/5678/04 | - |
| Almirall | 06320852 | ~£823,674,000 estimated from lot values | 1 lot CM/PHR/22/5678/02 | - |
| Amgen Ltd | 02354269 | ~£138,947,000 estimated from lot values | 1 lot CM/PHR/22/5678/03 | - |
| AstraZeneca | 02723534 | ~£1,316,705,000 estimated from lot values | 2 lots CM/PHR/22/5678/02 · CM/PHR/22/5678/04 | - |
| Aventis Pharma ltd t/a Sanofi | 01535640 | ~£1,694,387,000 estimated from lot values | 3 lots CM/PHR/22/5678/01 · CM/PHR/22/5678/02 · CM/PHR/22/5678/04 | DONOR£101K across 3 donations To: Pauline Latham MP, Derek Thomas, Labour Party |
| Bayer Plc | - | ~£377,682,000 estimated from lot values | 1 lot CM/PHR/22/5678/01 | - |
| Biogen | 06151086 | ~£377,682,000 estimated from lot values | 1 lot CM/PHR/22/5678/01 | - |
| Celltrion Healthcare United Kingdom Limited | 11685363 | ~£1,694,387,000 estimated from lot values | 3 lots CM/PHR/22/5678/01 · CM/PHR/22/5678/02 · CM/PHR/22/5678/04 | - |
| Chugai Pharma UK Ltd | 02814621 | ~£138,947,000 estimated from lot values | 1 lot CM/PHR/22/5678/03 | - |
| CST Pharma Limited | 04212740 | ~£377,682,000 estimated from lot values | 1 lot CM/PHR/22/5678/01 | - |
| Dr.Reddy's Laboratories (UK) Limited | 01729064 | ~£1,316,705,000 estimated from lot values | 2 lots CM/PHR/22/5678/02 · CM/PHR/22/5678/04 | - |
| Eli Lilly and Company Ltd | 00284385 | ~£1,694,387,000 estimated from lot values | 3 lots CM/PHR/22/5678/01 · CM/PHR/22/5678/02 · CM/PHR/22/5678/04 | DONOR£9K across 1 donation To: Conservative and Unionist Party LOBBYIST IPG DXTRA (UK) LIMITED (1 quarter) |
| Galapagos Biotech Ltd | 03400161 | ~£1,316,705,000 estimated from lot values | 2 lots CM/PHR/22/5678/02 · CM/PHR/22/5678/04 | - |
| Gedeon Richter UK Ltd | 04325685 | ~£1,316,705,000 estimated from lot values | 2 lots CM/PHR/22/5678/02 · CM/PHR/22/5678/04 | - |
| GlaxoSmithKline UK Limited | 04310159 | ~£1,316,705,000 estimated from lot values | 2 lots CM/PHR/22/5678/02 · CM/PHR/22/5678/04 | LOBBYIST Hill & Knowlton Limited (4 quarters) Global Counsel Ltd (1 quarter) |
| Ipsen | 06751069 | ~£516,629,000 estimated from lot values | 2 lots CM/PHR/22/5678/01 · CM/PHR/22/5678/03 | LOBBYIST Burkitt Communications Ltd (2 quarters) WA Communications Ltd (1 quarter) |
| Janssen-Cilag Ltd | 01027904 | ~£1,833,334,000 estimated from lot values | 4 lots CM/PHR/22/5678/01 · CM/PHR/22/5678/02 · CM/PHR/22/5678/03 · CM/PHR/22/5678/04 | LOBBYIST Ovid Consulting Ltd (4 quarters) |
| Merck Serono Limited | 00990823 | ~£516,629,000 estimated from lot values | 2 lots CM/PHR/22/5678/01 · CM/PHR/22/5678/03 | MP LINK Munira Wilson— Employment and earnings |
| Merck Sharpe and Dohme (UK) Limited | - | ~£1,316,705,000 estimated from lot values | 2 lots CM/PHR/22/5678/02 · CM/PHR/22/5678/04 | - |
| Merz | - | ~£138,947,000 estimated from lot values | 1 lot CM/PHR/22/5678/03 | - |
| Mylan | 05460854 | ~£377,682,000 estimated from lot values | 1 lot CM/PHR/22/5678/01 | - |
| Napp Pharmaceuticals Ltd | 03690299 | ~£516,629,000 estimated from lot values | 2 lots CM/PHR/22/5678/01 · CM/PHR/22/5678/03 | - |
| Neon Healthcare Ltd | 06844351 | ~£377,682,000 estimated from lot values | 1 lot CM/PHR/22/5678/01 | - |
| Novartis Pharmaceuticals UK Ltd | 00119006 | ~£1,694,387,000 estimated from lot values | 3 lots CM/PHR/22/5678/01 · CM/PHR/22/5678/02 · CM/PHR/22/5678/04 | DONOR£3K across 2 donations To: Mr Nicholas Palmer LOBBYIST M&F Health (7 quarters) Sovereign Strategy Limited (1 quarter) MP LINK Mr David Lammy— Employment and earnings |
| Novo Nordisk | 01118740 | ~£377,682,000 estimated from lot values | 1 lot CM/PHR/22/5678/01 | LOBBYIST WA Communications Ltd (7 quarters) Hanover Communications International Limited (2 quarters) MHP Communications (1 quarter) |
| Organon Pharmaceuticals UK Ltd | - | ~£493,031,000 estimated from lot values | 1 lot CM/PHR/22/5678/04 | - |
| Orifarm UK | 10015046 | ~£1,694,387,000 estimated from lot values | 3 lots CM/PHR/22/5678/01 · CM/PHR/22/5678/02 · CM/PHR/22/5678/04 | - |
| Pfizer Ltd | 00526209 | ~£1,833,334,000 estimated from lot values | 4 lots CM/PHR/22/5678/01 · CM/PHR/22/5678/02 · CM/PHR/22/5678/03 · CM/PHR/22/5678/04 | DONOR£41K across 4 donations To: Progressive Britain Ltd (formally Progress Ltd) LOBBYIST Portland PR Limited (20 quarters) Hanover Communications International Limited (3 quarters) Ovid Consulting Ltd (3 quarters) Incisive Health Ltd (1 quarter) MHP Communications (1 quarter) FORMER MP John Austin— Gifts, benefits and hospitality from UK sources (former) |
| Pharmacosmos UK Ltd | 03104505 | ~£138,947,000 estimated from lot values | 1 lot CM/PHR/22/5678/03 | - |
| Roche Products Ltd | 00100674 | ~£1,833,334,000 estimated from lot values | 4 lots CM/PHR/22/5678/01 · CM/PHR/22/5678/02 · CM/PHR/22/5678/03 · CM/PHR/22/5678/04 | LOBBYIST M&F Health (5 quarters) Ovid Consulting Ltd (2 quarters) |
| Sandoz Ltd | 01547204 | ~£516,629,000 estimated from lot values | 2 lots CM/PHR/22/5678/01 · CM/PHR/22/5678/03 | - |
| Sobi (Swedish Orphan Biovitrum Ltd) | - | ~£1,316,705,000 estimated from lot values | 2 lots CM/PHR/22/5678/02 · CM/PHR/22/5678/04 | - |
| Sun Pharma UK Ltd | 02992795 | ~£823,674,000 estimated from lot values | 1 lot CM/PHR/22/5678/02 | - |
| Teva UK Limited | 00302461 | ~£1,694,387,000 estimated from lot values | 3 lots CM/PHR/22/5678/01 · CM/PHR/22/5678/02 · CM/PHR/22/5678/04 | - |
| Thornton and Ross Ltd | 00185947 | ~£1,316,705,000 estimated from lot values | 2 lots CM/PHR/22/5678/02 · CM/PHR/22/5678/04 | - |
| Vifor Pharma UK Ltd | 06514784 | ~£138,947,000 estimated from lot values | 1 lot CM/PHR/22/5678/03 | - |
| Zentiva Pharma UK Ltd | 02158996 | ~£1,316,705,000 estimated from lot values | 2 lots CM/PHR/22/5678/02 · CM/PHR/22/5678/04 | - |
This procurement was divided into 4 lots, each awarded separately. 1450 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 CM/PHR/22/5678/01 Mar 2024 – Aug 2025 | £377,682,000 £19 initial term | 21 | Celltrion Healthcare United Kingdom Limited Biogen Neon Healthcare Ltd Pfizer Ltd Bayer Plc Sandoz Ltd Aventis Pharma ltd t/a Sanofi Mylan Merck Serono Limited Janssen-Cilag Ltd Eli Lilly and Company Ltd Roche Products Ltd Ipsen Napp Pharmaceuticals Ltd CST Pharma Limited Orifarm UK Teva UK Limited Novo Nordisk Novartis Pharmaceuticals UK Ltd | active |
| Lot 2 CM/PHR/22/5678/02 Mar 2024 – Aug 2025 | £823,674,000 £21 initial term | 21 | Zentiva Pharma UK Ltd GlaxoSmithKline UK Limited Celltrion Healthcare United Kingdom Limited Merck Sharpe and Dohme (UK) Limited Accord-UK Ltd Dr.Reddy's Laboratories (UK) Limited Pfizer Ltd Aventis Pharma ltd t/a Sanofi Sun Pharma UK Ltd Sobi (Swedish Orphan Biovitrum Ltd) Galapagos Biotech Ltd Thornton and Ross Ltd AstraZeneca Janssen-Cilag Ltd Eli Lilly and Company Ltd Roche Products Ltd Almirall Orifarm UK Teva UK Limited Novartis Pharmaceuticals UK Ltd Gedeon Richter UK Ltd | active |
| Lot 3 CM/PHR/22/5678/03 Mar 2024 – Aug 2026 | £138,947,000 £14 initial term | 15 | Amgen Ltd Accord-UK Ltd Pfizer Ltd Sandoz Ltd Vifor Pharma UK Ltd Chugai Pharma UK Ltd Abbvie Ltd Merck Serono Limited Janssen-Cilag Ltd Roche Products Ltd Ipsen Merz Napp Pharmaceuticals Ltd Pharmacosmos UK Ltd | active |
| Lot 4 CM/PHR/22/5678/04 Mar 2024 – Aug 2025 | £493,031,000 £20 initial term | 20 | Zentiva Pharma UK Ltd GlaxoSmithKline UK Limited Celltrion Healthcare United Kingdom Limited Merck Sharpe and Dohme (UK) Limited Accord-UK Ltd Dr.Reddy's Laboratories (UK) Limited Pfizer Ltd Aventis Pharma ltd t/a Sanofi Sobi (Swedish Orphan Biovitrum Ltd) Galapagos Biotech Ltd Thornton and Ross Ltd AstraZeneca Janssen-Cilag Ltd Eli Lilly and Company Ltd Roche Products Ltd Organon Pharmaceuticals UK Ltd Orifarm UK Teva UK Limited Novartis Pharmaceuticals UK Ltd Gedeon Richter UK Ltd | active |
Weightings from the notice, applied to every lot.
Government spending data: These suppliers have received £989,229,264 in 6,458 payments (over £25k) from UK Health Security Agency, Manchester University NHS Foundation Trust, Department of Health and Social Care, NHS England, Guy's and St Thomas' NHS FT and 22 more public bodies (2010-04-28 to 2026-03-31).
Changes the buyer published to this notice after it first appeared.
Published by the buyer on this notice. Check the original notice — details change and are not updated here.